Overview
Sovleplenib is a novel, investigational, selective small molecule inhibitor for oral administration targeting spleen tyrosine kinase (Syk). It is under investigation in clinical trial NCT03483948 (Phase I Study of Hmpl-523+azacitidine in Elderly Patients With Acute Myeloid Leukemia).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/03/04 | Phase 1 | Recruiting | |||
2023/03/23 | Phase 1 | Completed | |||
2023/02/09 | Phase 1 | Completed | |||
2022/10/07 | Phase 1 | Completed | |||
2022/04/08 | Early Phase 1 | Completed | Hutchison Medipharma Limited | ||
2021/08/31 | Phase 3 | Active, not recruiting | Hutchison Medipharma Limited | ||
2019/05/15 | Phase 1 | Completed | Hutchison Medipharma Limited | ||
2024/11/11 | Phase 1 | Completed | |||
2018/03/30 | Phase 1 | Terminated | Hutchison Medipharma Limited | ||
2016/08/05 | Phase 1 | Completed | Hutchison Medipharma Limited |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.